Another study by Sharma et al. revealed that radiotherapy activates ADAM17 in non-small cell lung cancer (NSCLC), inducing shedding of multiple survival factors, growth factor pathway activation, and IR-induced treatment resistance (66). The gene discussed is ADAM17; the disease is non-small cell lung carcinoma.